Neuroprotective Effects of Theobromine in permanent bilateral common carotid artery occlusion rat model of cerebral hypoperfusion
- PMID: 35587851
- DOI: 10.1007/s11011-022-00995-6
Neuroprotective Effects of Theobromine in permanent bilateral common carotid artery occlusion rat model of cerebral hypoperfusion
Abstract
Cerebral hypoperfusion (CH) is a common underlying mechanism of dementia disorders linked to aberrations in the neurovascular unit. Hemodynamic disturbances adversely affect cellular energy homeostasis that triggers a sequence of events leading to irrevocable damage to the brain and neurobehavioral discrepancies. Theobromine is a common ingredient of many natural foods consumed by a large population worldwide. Theobromine has shown health benefits in several studies, attributed to regulation of calcium homeostasis, phosphodiesterase, neurotransmission, and neurotrophins. The current study evaluated the neuroprotective potential of theobromine against CH in the permanent bilateral common carotid artery occlusion (BCCAO) prototype. Wistar rats were distributed in Sham-operated (S), S + T100, CH, CH + T50, and CH + T100 groups. Animals received permanent BCCAO or Sham treatment on day 1. Theobromine (50, 100 mg/kg) was given orally in animals subjected to BCCAO for 14 days daily. CH caused neurological deficits (12-point scale), motor dysfunction, and memory impairment in rats. Treatment with theobromine significantly attenuated neurological deficits and improved sensorimotor functions and memory in rats with CH. In biochemistry investigation of the entire brain, findings disclosed reduction in brain oxidative stress, inflammatory intermediaries (tumor necrosis factor-α, interleukin-1β and - 6, nuclear factor-κB), markers of cell demise (lactate dehydrogenase, caspase-3), acetylcholinesterase activity, and improvement in γ-aminobutyric acid quantity in rats that were given theobromine for 14 days daily after CH. Histopathological analysis substantiated attenuation of neurodegenerative changes by theobromine. The findings of this study indicated that theobromine could improve neurological scores, sensorimotor abilities, and memory in CH prototype.
Keywords: Cerebral hypoperfusion; GABA; Inflammation; Memory; Oxidative stress; Theobromine.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
The Therapeutic Potential of Theobromine in Obesity: A Comprehensive Review.Nutr Rev. 2025 May 1;83(5):859-868. doi: 10.1093/nutrit/nuae122. Nutr Rev. 2025. PMID: 39271172 Free PMC article. Review.
-
The Mechanisms of Cucurbitacin E as a Neuroprotective and Memory-Enhancing Agent in a Cerebral Hypoperfusion Rat Model: Attenuation of Oxidative Stress, Inflammation, and Excitotoxicity.Front Pharmacol. 2021 Dec 10;12:794933. doi: 10.3389/fphar.2021.794933. eCollection 2021. Front Pharmacol. 2021. PMID: 34955861 Free PMC article.
-
Neuroprotective effects of theobromine in transient global cerebral ischemia-reperfusion rat model.Biochem Biophys Res Commun. 2021 Sep 24;571:74-80. doi: 10.1016/j.bbrc.2021.07.051. Epub 2021 Jul 22. Biochem Biophys Res Commun. 2021. PMID: 34303966
-
Rutin protects against cognitive deficits and brain damage in rats with chronic cerebral hypoperfusion.Br J Pharmacol. 2014 Aug;171(15):3702-15. doi: 10.1111/bph.12725. Br J Pharmacol. 2014. Retraction in: Br J Pharmacol. 2015 Sep;172(18):4601. doi: 10.1111/bph.13264. PMID: 24758388 Free PMC article. Retracted.
-
Efficacy of Artemisia annua Linné in improving cognitive impairment in a chronic cerebral hypoperfusion-induced vascular dementia animal model.Phytomedicine. 2023 Apr;112:154683. doi: 10.1016/j.phymed.2023.154683. Epub 2023 Jan 31. Phytomedicine. 2023. PMID: 36738479
Cited by
-
Investigating Molecular Mechanisms in Ischemic Preconditioning-Induced Resiliency to Severe Acute Global Cerebral Ischemia Using a Mouse Model of Chronic Cerebral Hypoperfusion.Cell Mol Neurobiol. 2025 Mar 26;45(1):27. doi: 10.1007/s10571-025-01547-z. Cell Mol Neurobiol. 2025. PMID: 40138004 Free PMC article.
-
The Therapeutic Potential of Theobromine in Obesity: A Comprehensive Review.Nutr Rev. 2025 May 1;83(5):859-868. doi: 10.1093/nutrit/nuae122. Nutr Rev. 2025. PMID: 39271172 Free PMC article. Review.
-
Association between dietary theobromine and age-related macular degeneration: results from NHANES 2005-2008 and in vitro experiments.Eur J Med Res. 2025 Aug 5;30(1):714. doi: 10.1186/s40001-025-02946-0. Eur J Med Res. 2025. PMID: 40765005 Free PMC article.
-
Biological properties of caffeine, (+)-catechin, and theobromine: an in silico study.3 Biotech. 2024 Apr;14(4):94. doi: 10.1007/s13205-024-03934-7. Epub 2024 Mar 3. 3 Biotech. 2024. PMID: 38444785 Free PMC article.
-
From Cocoa to Chocolate: Effect of Processing on Flavanols and Methylxanthines and Their Mechanisms of Action.Int J Mol Sci. 2022 Nov 18;23(22):14365. doi: 10.3390/ijms232214365. Int J Mol Sci. 2022. PMID: 36430843 Free PMC article. Review.
References
-
- Ackerman S (1992) Discovering the brain. National Academies Press (US), Washington (DC)
-
- Asomugha CO, Linn DM, Linn CL (2010) ACh receptors link two signaling pathways to neuroprotection against glutamate-induced excitotoxicity in isolated RGCs. J Neurochem 112:214–226. https://doi.org/10.1111/j.1471-4159.2009.06447.x - DOI - PubMed
-
- Ayala A, Muñoz MF, Argüelles S (2014) Lipid peroxidation: Production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid Med Cell Longev 2014:360438. https://doi.org/10.1155/2014/360438 - DOI - PubMed - PMC
-
- Bacigaluppi M, Comi G, Hermann DM (2010) Animal models of ischemic stroke. Part two: Modeling cerebral ischemia. Open Neurol J 4:34–38. https://doi.org/10.2174/1874205X01004020034 - DOI - PubMed - PMC
-
- Bell RD, Zlokovic BV (2009) Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer’s disease. Acta Neuropathol 118:103–113. https://doi.org/10.1007/s00401-009-0522-3 - DOI - PubMed - PMC
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials